Grapefruit–medication interactions: Forbidden fruit or avoidable consequences?
Authors:
Top Cited Papers
- 26 November 2012
- journal article
- review article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 185 (4) , 309-316
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- A dangerous fruit juiceThe American Journal of Emergency Medicine, 2012
- Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice dailyBritish Journal of Clinical Pharmacology, 2011
- Fruit juice inhibition of uptake transport: a new type of food–drug interactionBritish Journal of Clinical Pharmacology, 2010
- Marginal increase of sunitinib exposure by grapefruit juiceCancer Chemotherapy and Pharmacology, 2010
- Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy ParticipantsThe Journal of Clinical Pharmacology, 2010
- Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Cancer Causes & Control, 2009
- Unusual causes of rhabdomyolysisInternal Medicine Journal, 2008
- Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort StudyBritish Journal of Cancer, 2007
- Age-related variations in flavonoid intake and sources in the Australian populationPublic Health Nutrition, 2006
- Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinBritish Journal of Clinical Pharmacology, 2004